Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis
Introduction: Repository corticotropin injection (RCI, Acthar® Gel) is a naturally sourced mixture of adrenocorticotropic hormone analogues and other pituitary peptides with anti-inflammatory and immunomodulatory effects. In a recent clinical trial, RCI was safe and effective for the treatment of re...
Saved in:
Main Authors: | Howard Busch (Author), George J Wan (Author), John Niewoehner (Author), Parul Houston (Author), Yujie Su (Author), Cassie Clinton (Author), Mary P Panaccio (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis
by: Bindra J, et al.
Published: (2021) -
Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis
by: Hunter SF, et al.
Published: (2021) -
Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis
by: George J Wan, et al.
Published: (2020) -
Corrigendum: Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis
by: George J Wan, et al.
Published: (2021) -
Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab
by: Knight T, et al.
Published: (2017)